Karl R VanDerMeid

Title: The Innovations of Karl R VanDerMeid

Introduction

Karl R VanDerMeid is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccine compositions. With a total of two patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

One of VanDerMeid's latest patents involves the isolation and purification of a 74-kilodalton outer membrane protein from Moraxella catarrhalis. This protein, designated as the 74 kD protein, has an amino-terminal amino acid sequence that is conserved among various strains. The protein has a molecular weight of approximately 74.9 kD as measured on a 10% SDS-PAGE gel, while its molecular weight as measured by mass spectrometry is approximately 74 kD. The 74 kD protein is utilized to prepare a vaccine composition that elicits a protective immune response in a mammalian host, aimed at protecting against diseases caused by this specific protein.

Career Highlights

Throughout his career, VanDerMeid has worked with prominent companies in the biotechnology sector. Notable among these are American Cyanamid Company and Wyeth Holdings Corporation. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.

Collaborations

VanDerMeid has collaborated with several professionals in his field, including Dexiang Chen and John C McMichael. These collaborations have likely enriched his research and development efforts, leading to advancements in vaccine technology.

Conclusion

Karl R VanDerMeid's contributions to biotechnology, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and vaccine development.